Wang, S.G., Xu, Y. and Xie, H. (2015) Astragaloside IV Prevents Lipopolysaccharide-Induced Injury in H9C2 Cardiomyocytes. Chinese Journal of Natural Medicines, 13, 127-132.
https://doi.org/10.1016/S1875-5364(15)60016-4

has been cited by the following article:

• TITLE: Potential Role of Astragaloside IV in the Treatment of Fungal Keratitis

  AUTHORS: Xiaoshuo Zheng, Wenfei Lian, Yang Liu

  KEYWORDS: Astragaloside IV, Inflammatory, Immune, Collagen Degradation, Fungal Keratitis

  JOURNAL NAME: Advances in Bioscience and Biotechnology, Vol.13 No.5, May 20, 2022

  ABSTRACT: Fungal keratitis (FK) is a worldwide visual impairment disease. The pathogenesis of fungal keratitis involves fungi, corneal cells, inflammatory cell infiltration, collagen degradation, inflammatory cytokines and their interactions. Accumulated evidence indicated that Astragaloside IV (AS-IV) possesses a broad range of pharmacological properties, such as efficacy in anti-inflammation, alleviating fibrosis, and immunomodulatory effects. This paper summarizes new findings regarding AS-IV in immune and inflammatory diseases and analyzes the perspective application of Astragaloside IV in fungal keratitis.